Baricinitib reduction after achieving remission may keep remission in RA patients
Not Applicable
Recruiting
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000037514
- Lead Sponsor
- Osaka city university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Those who were considered not suitable for the study by researchers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method risk factors for flare after baricitinib reduction
- Secondary Outcome Measures
Name Time Method